Christopher Mirabelli

CIK: 0001262326

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (23.1%)

Position reduction

Option Exercises (M)3 (23.1%)

Derivative conversions

Awards (A)3 (23.1%)

Compensation grants

Other (G, F, J, C, D, …)4 (30.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CYPH

CYPHERPUNK TECHNOLOGIES INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (13 total)

CYPH
CYPHERPUNK TECHNOLOGIES INC.
Mar 26, 2026
Sale(S)
Direct
60K shares at avg. $0.71$43K
CYPH
CYPHERPUNK TECHNOLOGIES INC.
Mar 13, 2026
Exercise(M)
Direct
74.7K shares-
CYPH
CYPHERPUNK TECHNOLOGIES INC.
Mar 13, 2026
Exercise(M)
Direct
94.1K shares-
CYPH
CYPHERPUNK TECHNOLOGIES INC.
Dec 23, 2025
Other(J)
Indirect
2.1K shares-
CYPH
CYPHERPUNK TECHNOLOGIES INC.
Dec 23, 2025
Other(J)
Direct
712 shares-
CYPH
CYPHERPUNK TECHNOLOGIES INC.
Dec 23, 2025
Award(A)
Restricted Stock Units
Direct
94.1K shares-
CYPH
CYPHERPUNK TECHNOLOGIES INC.
Nov 17, 2025
Sale(S)
Indirect
261.8K shares at avg. $3.14$822K
CYPH
CYPHERPUNK TECHNOLOGIES INC.
Nov 17, 2025
Sale(S)
Indirect
414.5K shares at avg. $3.14$1.3M
CYPH
CYPHERPUNK TECHNOLOGIES INC.
Nov 11, 2025
Award(A)
Restricted Stock Units
Direct
74.7K shares-
LPTX
LEAP THERAPEUTICS, INC.
Mar 28, 2025
Exercise(M)
Direct
22.5K shares-
LPTX
LEAP THERAPEUTICS, INC.
Mar 28, 2025
Tax Payment(F)
Direct
6.7K shares at avg. $0.32$2K
LPTX
LEAP THERAPEUTICS, INC.
Nov 13, 2024
In-the-Money(X)
Indirect
2.1K shares at avg. $2.82$6K
LPTX
LEAP THERAPEUTICS, INC.
Oct 2, 2024
Award(A)
Stock Option (Right to Buy)
Direct
85K shares-

		Type	Shares	Price		Ownership
Mar 26, 2026	CYPH CYPHERPUNK TECHNOLOGIES INC.	Sale(S)	60,000	$0.71	$42,630	Direct
Mar 13, 2026	CYPH CYPHERPUNK TECHNOLOGIES INC.	Exercise(M)	74,700	-	$0	Direct
Mar 13, 2026	CYPH CYPHERPUNK TECHNOLOGIES INC.	Exercise(M)	94,050	-	$0	Direct
Dec 23, 2025	CYPH CYPHERPUNK TECHNOLOGIES INC.	Other(J)	2,136	-	-	Indirect
Dec 23, 2025	CYPH CYPHERPUNK TECHNOLOGIES INC.	Other(J)	712	-	-	Direct
Dec 23, 2025	CYPH CYPHERPUNK TECHNOLOGIES INC.	Award(A) Restricted Stock Units	94,050	-	-	Direct
Nov 17, 2025	CYPH CYPHERPUNK TECHNOLOGIES INC.	Sale(S)	261,840	$3.14	$822,178	Indirect
Nov 17, 2025	CYPH CYPHERPUNK TECHNOLOGIES INC.	Sale(S)	414,479	$3.14	$1,301,464	Indirect
Nov 11, 2025	CYPH CYPHERPUNK TECHNOLOGIES INC.	Award(A) Restricted Stock Units	74,700	-	-	Direct
Mar 28, 2025	LPTX LEAP THERAPEUTICS, INC.	Exercise(M)	22,500	-	-	Direct
Mar 28, 2025	LPTX LEAP THERAPEUTICS, INC.	Tax Payment(F)	6,672	$0.32	$2,112	Direct
Nov 13, 2024	LPTX LEAP THERAPEUTICS, INC.	In-the-Money(X)	2,136	$2.82	$6,024	Indirect
Oct 2, 2024	LPTX LEAP THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	85,000	-	-	Direct

1-13 of 13 transactions

About Mirabelli Christopher

Mirabelli Christopher (SEC CIK 0001262326) files insider reports with the SEC as Director of CYPHERPUNK TECHNOLOGIES INC. (CYPH).

Signal8 holds 8 ownership filings by Mirabelli Christopher, all Form 4s, filed between Oct 4, 2024 and Mar 30, 2026. Those filings report 13 transactions, from Oct 2, 2024 to Mar 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Mirabelli Christopher's filings is in CAMBRIDGE, MA.

Recent filings by Mirabelli Christopher

Mar 26, 2026: Open-market sale of CYPH shares (Form 4, code S).
Mar 13, 2026: Option exercises of CYPH shares (2 lines, Form 4, code M).
Dec 23, 2025: Other transactions of CYPH shares (2 lines, Form 4, code J).
Dec 23, 2025: Grant or award of CYPH derivative securities (Form 4, code A).
Nov 17, 2025: Open-market sales of CYPH shares (2 lines, Form 4, code S).

Other insiders filing for CYPHERPUNK TECHNOLOGIES INC. (CYPH)

Winklevoss Capital Fund, LLC, 10% Owner
McEvoy William Patrick III, Chief Investment Officer
Fabiano Amanda, Director
Oei Khing Djien, Director
Martin Patricia A., Director
Dietz Thomas John, Director

How to read Form 4 transaction codes